Secondary prevention antibiotic treatment trials.
Conti
C R
CR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy*; D002690:Chlamydia Infections / Q000188:drug therapy; D006801:Humans
D000900:Anti-Bacterial Agents